NHS North West Genomics
2.2.0 - ci-build United Kingdom flag

NHS North West Genomics - Local Development build (v2.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: NHS England Digital Genomic Test Services

Official URL: https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices Version: 2.2.0
Active as of 2026-09-08 Computable Name: DigitalGenomicTestServices

The digital National Genomic Test Directory codes, rolled out as the Test Directory itself went digital - replacing the legacy R-code/M-code style codes in NHS England Genomic Test Code ($GTD, England-GenomicTestDirectory) for new/migrated indications. Two code types share this one system, distinguished by prefix:

  • TP (Test Package) codes replace the old clinical-indication concept - a package of related genomic tests grouped by clinical condition.
  • GT (Genomic/Genetic Test) codes identify a single specific laboratory investigation.

Refreshed from the Haematological Oncology (v1.1) and Cancer CNS (v2) national genomic test directories on 2026-09-08 - see ConceptMap-GenomicTestCodeToDigitalGenomicTestServices and ConceptMap-GenomicClinicalIndicationToDigitalGenomicTestServices for how these relate to the legacy codes they replace.

category is mostly file-derived (haem-onc v1.1 -> haematological-oncology, CNS v2 -> cancer) but not entirely - a handful of codes are curated by hand outside this notebook (e.g. TP401 "Chimerism Testing" -> chimerism) and preserved across reruns rather than re-derived; see notebook 14's own note on this for the full reasoning. test-method (GT codes only) comes straight from each source row's own "Test Method" column, refreshed fresh every run. No specialist-test-group here - neither source directory has an equivalent column.

This Code system is referenced in the definition of the following value sets:

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
Parent parent http://hl7.org/fhir/concept-properties#parent code The Test Package (TP) code(s) this Genomic Test (GT) code belongs to
category category https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices#category code Which part of the National Genomic Test Directory this code belongs to: rare-and-inherited-disease, cancer, haematological-oncology, or chimerism
test-method test-method https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices#test-method string The test method/technology used, from the source directory's own Test Method column (Genomic/Genetic Test (GT) codes only - a Test Package (TP) can bundle more than one technology)

Concepts

This case-sensitive code system https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices provides a fragment that includes following codes:

CodeDisplayParentcategorytest-method
TP34 Acute Lymphoblastic Leukaemia - T cell haematological-oncology
TP58 Mature T Cell Neoplasms haematological-oncology
TP62 Clonality Testing haematological-oncology
TP126 Myeloma haematological-oncology
TP171 Cystic renal disease rare-and-inherited-disease
TP182 Histiocytosis haematological-oncology
TP202 Myelodysplastic Syndromes haematological-oncology
TP228 Myeloproliferative Neoplasm haematological-oncology
TP241 Acute Lymphoblastic Leukaemia - B cell haematological-oncology
TP245 Haematological Tumours - Exhausted SOC haematological-oncology
TP374 Chronic Myeloid Leukaemia haematological-oncology
TP377 Mature B Cell Neoplasms haematological-oncology
TP401 Chimerism Testing chimerism
TP450 Acute Myeloid Leukaemia haematological-oncology
TP533 Chronic Lymphocytic Leukaemia haematological-oncology
TP604 Embryonal tumours of the CNS cancer
TP613 Meningiomas cancer
TP622 Tumours of the Sellar Region and Pituitary Tumours cancer
TP623 Cranial and Paraspinal Nerve Tumours cancer
TP624 Choroid Plexus Tumours cancer
TP625 CNS of uncertain differentiation (NOS) and Rare Tumours cancer
TP640 Gliomas, Glioneuronal Tumours, and Neuronal tumours cancer
GT6 Small variant (IDH2) TP640 cancer Targeted assay
GT7 CRLF2, Xp22/Yp11 FISH - ALL TP241 haematological-oncology Targeted assay
GT10 TAL1, 1p33 FISH - T-ALL TP34 haematological-oncology Targeted assay
GT12 WGS Tumour First - Systemic mastocytosis TP228 haematological-oncology Whole Genome Sequencing
GT13 JAK2, 9q24 FISH - MPN TP228 haematological-oncology Targeted assay
GT14 Chromosome 12 CNV FISH - AML TP450 haematological-oncology Targeted assay
GT17 SNP Array - AML TP450 haematological-oncology Microarray
GT24 WGS Tumour First - AML TP450 haematological-oncology Whole Genome Sequencing
GT27 MYC rearrangement FISH TP604, TP640 cancer Targeted assay
GT31 MRD BCR::ABL1 - AML, ALL & CML TP241, TP34, TP374, TP450 haematological-oncology Targeted assay
GT35 WGS Tumour First - Histiocytosis TP182 haematological-oncology Whole Genome Sequencing
GT39 T Cell Clonality Testing - Multiplex Sequencing TP62 haematological-oncology Sequencing
GT40 IGH::FGFR3, t(4;14)(p16;q32) FISH - Myeloma TP126 haematological-oncology Targeted assay
GT50 Next Generation Sequencing RNA Panel - Structural Variants - Mature B Cell Neoplasms TP377 haematological-oncology Sequencing
GT52 JAK2, 9p24.1 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT56 IGH, 14q32 FISH - B-ALL TP241 haematological-oncology Targeted assay
GT59 TCL1A, 14q32 FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT61 DEK::NUP214, t(6;9)(p22;q34) FISH or RT-PCR - AML TP450 haematological-oncology Targeted assay
GT69 BRAF Hotspot (V600E) High Sensitivity - Histiocytosis TP182 haematological-oncology Targeted assay
GT71 Chromosome 19 CNV FISH - CML TP374 haematological-oncology Targeted assay
GT73 Chromosome 7 CNV FISH - CML TP374 haematological-oncology Targeted assay
GT74 NUP98::NSD1, t(5;11)(q35;p15.5) FISH - AML TP450 haematological-oncology Targeted assay
GT75 Next Generation Sequencing Panel - Copy Number Variants - Myeloma TP126 haematological-oncology Sequencing
GT85 ABL1, 9q34 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT88 WGS Tumour First - exhausted SOC TP245 haematological-oncology Whole Genome Sequencing
GT99 Next Generation Sequencing Panel - Structural Variants - CML TP374 haematological-oncology Sequencing
GT100 SNP Array - MPN TP228 haematological-oncology Microarray
GT101 RUNX1::RUNX1T1, t(8;21)(q22;q22) FISH or RT-PCR - AML TP450 haematological-oncology Targeted assay
GT104 WGS Germline & Tumour - exhausted SOC TP245 haematological-oncology Whole Genome Sequencing
GT112 RBM15::MRTFA, t(1;22)(p13;q13) FISH - AML TP450 haematological-oncology Targeted assay
GT120 MALT1, 18q21 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT128 WGS Follow-up Germline - MDS/MPN TP202 haematological-oncology Whole Genome Sequencing
GT131 BCOR CNV FISH TP604 cancer Targeted assay
GT133 PML::RARA, t(15;17)(q24;q21) FISH or RT-PCR - AML TP450 haematological-oncology Targeted assay
GT147 FGFR1, 8p11 FISH - MPN TP228 haematological-oncology Targeted assay
GT152 ABL1, 9q34 FISH - MPN TP228 haematological-oncology Targeted assay
GT157 GATA2::MECOM, inv(3)(q21q26) FISH - AML TP450 haematological-oncology Targeted assay
GT160 Ploidy Status CNV FISH - ALL TP241 haematological-oncology Targeted assay
GT172 MECOM, 3q21 FISH - MDS & MPN TP202, TP228 haematological-oncology Targeted assay
GT178 SNP Array - Myeloma TP126 haematological-oncology Microarray
GT180 NPM1::MLF1, t(3;5)(q25;q34) FISH - AML TP450 haematological-oncology Targeted assay
GT183 WGS Germline & Tumour - T-ALL TP34 haematological-oncology Whole Genome Sequencing
GT185 Next Generation Sequencing Panel - Structural Variants - AML TP450 haematological-oncology Sequencing
GT187 IGH::CCND1, t(11;14)(q13;q32) FISH - Myeloma TP126 haematological-oncology Targeted assay
GT198 Chromosome 7 CNV FISH - MDS & MPN TP202, TP228 haematological-oncology Targeted assay
GT200 Other FISH Targets - ALL TP241, TP34 haematological-oncology Targeted assay
GT214 Other MRD Targets - B-ALL TP241 haematological-oncology Targeted assay
GT217 Genome-wide DNA Methylation Profiling TP604, TP613, TP622, TP623, TP624, TP625, TP640 cancer Targeted assay
GT225 WGS Follow-up Germline - T-ALL TP34 haematological-oncology Whole Genome Sequencing
GT231 Chromosome 11 CNV FISH - CLL TP533 haematological-oncology Targeted assay
GT236 BRAF rearrangement FISH TP604, TP640 cancer Targeted assay
GT237 EWSR1 rearrangement FISH TP640 cancer Targeted assay
GT239 TLX1::, 10q24 FISH - T-ALL TP34 haematological-oncology Targeted assay
GT246 KIT Hotspot (D816) High Sensitivity - Systemic Mastocytosis TP228 haematological-oncology Targeted assay
GT253 Next Generation Sequencing Panel - Small Variants - AML TP450 haematological-oncology Sequencing
GT254 WGS Tumour First - Acute leukaemia other TP241 haematological-oncology Whole Genome Sequencing
GT256 IRF4/DUSP22, 6p25 FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT258 MLLT3::KMT2A, t(9;11)(p21;q23) & other KMT2A rearrangements FISH or RT-PCR - AML TP450 haematological-oncology Targeted assay
GT259 Meningioma WGS - Paediatric and Adult TP613 cancer Whole Genome Sequencing
GT265 WGS Germline & Tumour - MDS/MPN TP202 haematological-oncology Whole Genome Sequencing
GT267 Next Generation Sequencing Panel - Small Variants - Mature B Cell Neoplasms TP377 haematological-oncology Sequencing
GT272 MYD88 Hotspot (L265P Variants) - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT275 CBFB::MYH11, inv(16)(p13.1q22) FISH or RT-PCR - AML TP450 haematological-oncology Targeted assay
GT279 1p19q CNV FISH TP640 cancer Targeted assay
GT289 CBFA2T3::GLIS2, inv(16)(p13.3q24.3) FISH - AML TP450 haematological-oncology Targeted assay
GT295 SNP Array - B-ALL TP241 haematological-oncology Microarray
GT296 ABL2, 1q25 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT301 KMT2A, 11q23 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT303 BCR::ABL1 TKD Variants - AML, ALL & CML TP241, TP34, TP374, TP450 haematological-oncology Sequencing
GT304 WGS Follow-up Germline - AA TP202 haematological-oncology Whole Genome Sequencing
GT306 Next Generation Sequencing Panel - Copy Number Variants - Mature B Cell Neoplasms TP377 haematological-oncology Sequencing
GT312 IGL::MYC, t(8;22)(q24;q11) FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT315 TCF3, 19p13 FISH - ALL TP241 haematological-oncology Targeted assay
GT321 BRAF Hotspot (V600E Variants) - Hairy Cell Leukaemia TP377 haematological-oncology Targeted assay
GT326 MPL Hotspot (exon 10) - MPN TP228 haematological-oncology Targeted assay
GT329 Next Generation Sequencing Panel - Structural Variants - ALL TP241, TP34 haematological-oncology Sequencing
GT332 MRD Target Identification - T-ALL TP34 haematological-oncology Sequencing
GT338 Chromosome 13 CNV FISH - CLL TP533 haematological-oncology Targeted assay
GT343 MRD RUNX1::RUNX1T1 - AML TP450 haematological-oncology Targeted assay
GT345 Chromosome 7 CNV FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT350 Next Generation Sequencing Panel - Copy Number Variants - ALL TP241, TP34 haematological-oncology Sequencing
GT351 Other RT-PCR Targets - AML TP450 haematological-oncology Targeted assay
GT353 CDKN2A CNV FISH TP640 cancer Targeted assay
GT355 Chromosome 17 CNV FISH - MPN TP228 haematological-oncology Targeted assay
GT369 IRF4, 6p25 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT373 PDGFRA, 4q21 FISH - MPN TP228 haematological-oncology Targeted assay
GT383 Chromosome 17 CNV FISH - Myeloma TP126 haematological-oncology Targeted assay
GT386 Next Generation Sequencing Panel - Structural Variants - MPN TP228 haematological-oncology Sequencing
GT397 Next Generation Sequencing Panel - Copy Number Variants - MDS TP202 haematological-oncology Sequencing
GT414 EZH2, 7q36 CNV FISH - Mature B Cell Neoplams TP377 haematological-oncology Targeted assay
GT426 BRAF, 7q34 FISH - Histiocytosis TP182 haematological-oncology Targeted assay
GT429 Next Generation Sequencing Panel - Small Variants - Myeloma TP126 haematological-oncology Sequencing
GT431 NTRK - Multi-target NGS panel - structural variants TP604, TP613, TP622, TP624, TP640 cancer Sequencing
GT444 SNP Array - Mature B Cell Neoplasms TP377 haematological-oncology Microarray
GT453 RELA rearrangement FISH TP604, TP640 cancer Targeted assay
GT456 NTRK1, 1q23 FISH - Histiocytosis TP182 haematological-oncology Targeted assay
GT467 WGS Germline & Tumour - B-ALL TP241 haematological-oncology Whole Genome Sequencing
GT468 FIP1L1::PDGFRA, 4q12 FISH - MPN TP228 haematological-oncology Targeted assay
GT475 MRD PML::RARA - AML TP450 haematological-oncology Targeted assay
GT478 KMT2A, 11q23 FISH - CML TP374 haematological-oncology Targeted assay
GT479 Chromosome 11q CNV FISH - B Cell Lymphoma with 11q Aberration TP377 haematological-oncology Targeted assay
GT483 IGL::MYC, t(8;22)(q24;q11) FISH - ALL TP241 haematological-oncology Targeted assay
GT494 IDH1 Hotspot (R132 Variants) - AML TP450 haematological-oncology Targeted assay
GT497 Cystic renal disease - WGS TP171 rare-and-inherited-disease
GT508 T Cell Clonality Testing - NGS TP62 haematological-oncology Sequencing
GT512 KMT2A::AFDN, t(6;11)(q27;q23) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT517 WGS Germline & Tumour - BPDCN TP450 haematological-oncology Whole Genome Sequencing
GT527 SNP Array - T-ALL TP34 haematological-oncology Microarray
GT533 FLT3 ITD Targeted Assay - AML TP450 haematological-oncology Targeted assay
GT534 REL, 2p16 CNV FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT538 WGS Germline & Tumour - CML TP374 haematological-oncology Whole Genome Sequencing
GT543 WGS Tumour First - MPN TP228 haematological-oncology Whole Genome Sequencing
GT546 IGK::MYC, t(2;8)(p12;q24) FISH TP241 haematological-oncology Targeted assay
GT548 ETV6::RUNX1, t(12;21)(p13;q22) & iAMP21 FISH - B-ALL TP241 haematological-oncology Targeted assay
GT549 IGH::MAF, t(14;16)(q32;q23) FISH - Myeloma TP126 haematological-oncology Targeted assay
GT551 IGHV Hypermutation (Multiplex Sequencing) - CLL TP533 haematological-oncology Sequencing
GT552 WGS Germline & Tumour - MPN TP228 haematological-oncology Whole Genome Sequencing
GT565 Other FISH Targets - Myeloma TP126 haematological-oncology Targeted assay
GT576 MYC::IGH, t(8;14)(q34;q32) FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT577 ETV6::RUNX1, t(12;21)(p13;q22) RT-PCR - ALL TP241 haematological-oncology Targeted assay
GT579 ALK, 2p23 FISH - Histiocytosis TP182 haematological-oncology Targeted assay
GT583 YAP1 rearrangement FISH TP604, TP640 cancer Targeted assay
GT592 BRAF::KIAA1549 rearrangement TP604, TP640 cancer Targeted assay
GT593 WGS Germline & Tumour - Histiocytosis TP182 haematological-oncology Whole Genome Sequencing
GT595 Chromosome 17 CNV FISH - MDS TP202 haematological-oncology Targeted assay
GT613 BCL2, 18q21 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT614 Other RT-PCR Targets - MPN TP228 haematological-oncology Targeted assay
GT629 Next Generation Sequencing Panel - Copy Number Variants - AML TP450 haematological-oncology Sequencing
GT632 MYC, 8q24 FISH - Myeloma TP126 haematological-oncology Targeted assay
GT634 MYCN CNV FISH TP604, TP640 cancer Targeted assay
GT635 SNP Array - MDS TP202 haematological-oncology Microarray
GT637 CCND2, 12p13 FISH - Mantle Cell Lymphoma TP377 haematological-oncology Targeted assay
GT646 IGH::BCL2, t(14;18)(q32;q21) FISH - Follicular Lymphoma TP377 haematological-oncology Targeted assay
GT649 BCR::ABL1 multiplex - CML, ALL or AML TP228, TP241, TP34, TP374, TP450 haematological-oncology Targeted assay
GT656 MNX1::ETV6, t(7;12)(q36;p13) FISH - AML TP450 haematological-oncology Targeted assay
GT662 MRD FIP1L1::PDGFRA - MPN TP228 haematological-oncology Targeted assay
GT664 IGK::MYC, t(2;8)(p12;q24) FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT665 Other FISH Targets - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT670 WGS Germline & Tumour - Acute leukaemia other TP241 haematological-oncology Whole Genome Sequencing
GT673 MRD BCR::ABL1 Rare Transcripts - AML, ALL & CML TP241, TP34, TP374, TP450 haematological-oncology Targeted assay
GT687 WGS Tumour First - T-ALL TP34 haematological-oncology Whole Genome Sequencing
GT690 MECOM, 3q21 FISH - CML TP374 haematological-oncology Targeted assay
GT694 NUDT15, 13q14 Pharmacogenomic Test - ALL TP241, TP34 haematological-oncology Targeted assay
GT699 FIP1L1::PDGFRA, 4q12 FISH or RT-PCR - MPN TP228 haematological-oncology Targeted assay
GT700 Chromosome 7 CNV FISH - AML TP450 haematological-oncology Targeted assay
GT701 Next Generation Sequencing Panel - Structural Variants - MDS TP202 haematological-oncology Sequencing
GT702 WGS Tumour First - JMML TP202 haematological-oncology Whole Genome Sequencing
GT703 Other MRD Targets - AML TP450 haematological-oncology Targeted assay
GT716 Other FISH Targets - AML TP450 haematological-oncology Targeted assay
GT717 Next Generation Sequencing Panel - Small Variants (Limited) - MPN TP228 haematological-oncology Sequencing
GT720 Neurological Tumours-EGFRvIII-RT-PCR TP640 cancer Targeted assay
GT723 BCL6, 3q27 FISH - ALL TP241 haematological-oncology Targeted assay
GT725 IGH, 14q32 FISH - Myeloma TP126 haematological-oncology Targeted assay
GT726 WGS Germline & Tumour - AML TP450 haematological-oncology Whole Genome Sequencing
GT729 IGH::MYC, t(8;14)(q34;q32) FISH - ALL TP241 haematological-oncology Targeted assay
GT733 TP63, 3q28 FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT736 Next Generation Sequencing Panel - Copy Number Variants - MPN TP228 haematological-oncology Sequencing
GT738 MRD Target Identification - B-ALL TP241 haematological-oncology Sequencing
GT739 Other RT-PCR Targets - ALL TP241, TP34 haematological-oncology Targeted assay
GT746 IGH::MAFB, t(14;20)(q32;q12) FISH - Myeloma TP126 haematological-oncology Targeted assay
GT756 MYC, 8q24 FISH - ALL TP241 haematological-oncology Targeted assay
GT763 BCR::ABL1, t(9;22)(q34;q11) FISH - MPN TP228 haematological-oncology Targeted assay
GT777 BCOR rearrangement FISH TP604 cancer Targeted assay
GT778 MYB rearrangement TP640 cancer FISH
GT779 BCL10, 1p22 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT781 WGS Tumour First - B-ALL TP241 haematological-oncology Whole Genome Sequencing
GT790 MYC CNV FISH TP604, TP640 cancer Targeted assay
GT795 Next Generation Sequencing (DNA Based) Panel - Structural Variants - Mature B Cell Neoplasms TP377 haematological-oncology Sequencing
GT802 WGS Follow-up Germline - AML TP450 haematological-oncology Whole Genome Sequencing
GT818 PCM1::JAK2, t(8;9)(p22;q24) FISH - MPN TP228 haematological-oncology Targeted assay
GT819 Next Generation Sequencing Panel - Small Variants - MPN TP228 haematological-oncology Sequencing
GT821 Next Generation Sequencing (DNA Based) Panel - Structural Variants - Mature T Cell Neoplasms TP58 haematological-oncology Sequencing
GT825 WGS Follow-up Germline - Acute Leukaemia Other TP241 haematological-oncology Whole Genome Sequencing
GT836 WGS Follow-up Germline - Histiocytosis TP182 haematological-oncology Whole Genome Sequencing
GT844 KMT2A::MLLT3, t(9;11)(p21;q23) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT849 Next Generation Sequencing Panel - Small Variants - ALL TP241, TP34 haematological-oncology Sequencing
GT852 IGH, 14q32 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT854 SNP Array TP604, TP625 cancer Microarray
GT855 CKS1B, 1q21 & CDKN2C, 1p32 CNV FISH - Myeloma TP126 haematological-oncology Targeted assay
GT868 CCND1, 11q13 FISH - Mantle Cell Lymphoma TP377 haematological-oncology Targeted assay
GT870 MRD CBFB::MYH11 - AML TP450 haematological-oncology Targeted assay
GT874 TCF3::PBX1, t(1;19)(q23;p13) & TCF3::HLF, t(17;19)(q22;p13) FISH - ALL TP241 haematological-oncology Targeted assay
GT879 WGS Tumour First - BPDCN TP450 haematological-oncology Whole Genome Sequencing
GT889 WGS Tumour First - MDS/MPN TP202 haematological-oncology Whole Genome Sequencing
GT890 IGH::CCND3, t(6;14)(p21;q32) FISH - Myeloma TP126 haematological-oncology Targeted assay
GT892 Next Generation Sequencing Panel - Small Variants - Histiocytosis TP182 haematological-oncology Sequencing
GT913 ALK rearrangement FISH TP604 cancer Targeted assay
GT914 Next Generation Sequencing Panel - Structural Variants - Histiocytosis TP182 haematological-oncology Sequencing
GT916 FLT3 TKD Targeted Assay - AML TP450 haematological-oncology Targeted assay
GT918 Karyotype - Mature B & T Cell Neoplasm TP377, TP58 haematological-oncology Chromosome analysis
GT921 NPM1 Hotspot (exon 12) - AML TP450 haematological-oncology Targeted assay
GT923 Chromosome 17 CNV FISH - CLL TP533 haematological-oncology Targeted assay
GT926 Other FISH Targets - CLL TP533 haematological-oncology Targeted assay
GT929 Next Generation Sequencing Panel - Copy Number Variants - CLL TP533 haematological-oncology Sequencing
GT935 SNP Array - CLL TP533 haematological-oncology Microarray
GT939 Other FISH Targets - MDS TP202 haematological-oncology Targeted assay
GT943 Embryonal Tumours WGS - Paediatric and Adult TP604 cancer Whole Genome Sequencing
GT944 MGMT promoter hypermethylation - methylation specific PCR TP622, TP625, TP640 cancer Targeted assay
GT965 JAK2 Hotspot (exon 12) - MPN TP228 haematological-oncology Targeted assay
GT985 Other MRD Targets - T-ALL TP34 haematological-oncology Targeted assay
GT986 JAK2 Hotspot (V617F) - MPN TP228 haematological-oncology Targeted assay
GT999 WGS Germline & Tumour - ALK Positive Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1002 WGS Follow-up Germline - ALK Positive Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1007 FOXP1, 3p13 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1008 WGS Tumour First - ALK Positive Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1012 PTEN CNV FISH TP604, TP640 cancer Targeted assay
GT1015 Chromosome 12 CNV FISH - MPN TP228 haematological-oncology Targeted assay
GT1023 WGS Follow-up Germline - MDS TP202 haematological-oncology Whole Genome Sequencing
GT1029 WGS Follow-up Germline - Systemic Mastocytosis TP228 haematological-oncology Whole Genome Sequencing
GT1033 BCR::ABL1, t(9;22)(q34;q11) FISH - AML TP450 haematological-oncology Targeted assay
GT1034 Chromosome 8 CNV FISH - CML TP374 haematological-oncology Targeted assay
GT1042 CALR Hotspot (exon 9) - MPN TP228 haematological-oncology Targeted assay
GT1049 EGFR CNV FISH TP622, TP640 cancer Targeted assay
GT1050 WGS Follow-up Germline - B-ALL TP241 haematological-oncology Whole Genome Sequencing
GT1052 BCL2, 18q21 FISH - ALL TP241 haematological-oncology Targeted assay
GT1062 MRD NPM1 - AML TP450 haematological-oncology Targeted assay
GT1063 WGS Germline & Tumour - Systemic mastocytosis TP228 haematological-oncology Whole Genome Sequencing
GT1064 Chromosome 17 CNV FISH - AML TP450 haematological-oncology Targeted assay
GT1076 WGS Follow-up Germline - exhausted SOC TP245 haematological-oncology Whole Genome Sequencing
GT1089 PDGFRA, 4q12 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1096 Karyotype - AML, ALL & CML TP241, TP34, TP374, TP450 haematological-oncology Chromosome analysis
GT1114 WGS Follow-up Germline - JMML TP202 haematological-oncology Whole Genome Sequencing
GT1129 CDKN2B CNV FISH TP640 cancer Targeted assay
GT1138 MYBL1 rearrangement TP640 cancer FISH
GT1146 TCR FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT1149 MRD Quantification - T-ALL TP34 haematological-oncology Targeted assay
GT1153 Next Generation Sequencing RNA Panel - Structural Variants - Mature T Cell Neoplasms TP58 haematological-oncology Sequencing
GT1163 BCR::ABL1, t(9;22)(q34;q11) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1166 NUP98, 11p15 FISH - AML TP450 haematological-oncology Targeted assay
GT1180 PDGFRB / CSF1R, 5q32 FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1181 IGHV Hypermutation (NGS) - CLL TP533 haematological-oncology Sequencing
GT1185 TPMT, 6p22 Pharmacogenomic Test - ALL TP241, TP34 haematological-oncology Targeted assay
GT1191 KMT2A::AFF1, t(4;11)(q21;q23) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1193 Other FISH Targets - CML TP374 haematological-oncology Targeted assay
GT1209 Next Generation Sequencing Panel - Small Variants - CLL TP533 haematological-oncology Sequencing
GT1211 Other FISH Targets - MPN TP228 haematological-oncology Targeted assay
GT1221 WGS Follow-up Germline - BPDCN TP450 haematological-oncology Whole Genome Sequencing
GT1224 Chromosome 5 CNV FISH - MDS & MPN TP202, TP228 haematological-oncology Targeted assay
GT1228 MRD NPM1 Rare Transcripts - AML TP450 haematological-oncology Targeted assay
GT1233 Karyotype - MPN TP228 haematological-oncology Chromosome analysis
GT1236 WGS Follow-up Germline - MPN TP228 haematological-oncology Whole Genome Sequencing
GT1238 WGS Germline & Tumour - JMML TP202 haematological-oncology Whole Genome Sequencing
GT1247 MRD Quantification - B-ALL TP241 haematological-oncology Targeted assay
GT1248 Chromosome 8 CNV FISH - MDS & MPN TP202, TP228 haematological-oncology Targeted assay
GT1253 IGHV hypermutation (Multiplex Sequencing) - Hairy Cell Leukaemia TP377 haematological-oncology Sequencing
GT1258 TP53 deletion CNV FISH TP604 cancer Targeted assay
GT1260 Ependymal Tumours Differential Diagnosis-NGS Panel SNV and CNV TP640 cancer Sequencing
GT1265 SNP Array - CML TP374 haematological-oncology Microarray
GT1274 Next Generation Sequencing Panel - Structural Variants - Myeloma TP126 haematological-oncology Sequencing
GT1277 Hyperdiploidy CNV FISH or MLPA - Myeloma TP126 haematological-oncology Targeted assay
GT1279 Next Generation Sequencing Panel - Small Variants - Mature T Cell Neoplasms TP58 haematological-oncology Sequencing
GT1280 MN1 rearrangement TP604, TP640 cancer FISH
GT1281 Chromosome 12 CNV FISH - CLL TP533 haematological-oncology Targeted assay
GT1282 ETV6::PDGFRB, t(5;12)(q33;p13) FISH - MPN TP228 haematological-oncology Targeted assay
GT1285 BCL6, 3q27 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1294 Chromosome 5 CNV FISH - AML TP450 haematological-oncology Targeted assay
GT1297 Next Generation Sequencing Panel - Small Variants - MDS TP202 haematological-oncology Sequencing
GT1300 KMT2A::ELL, t(11;19)(q23;p13.1) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1302 Chromosome 20 CNV FISH - MDS TP202 haematological-oncology Targeted assay
GT1308 KMT2A::MLLT10, t(10;11)(p12;q23) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1309 KMT2A::MLLT1, t(11;19)(q23;p13.3) FISH - ALL TP241, TP34 haematological-oncology Targeted assay
GT1312 WGS Germline & Tumour - MDS TP202 haematological-oncology Whole Genome Sequencing
GT1317 Small variant (IDH1) TP640 cancer Targeted assay
GT1332 ZFTA rearrangements FISH TP640 cancer Targeted assay
GT1333 Structural variant, not otherwise specified - Targeted Variant Test TP604, TP640 cancer Targeted assay
GT1334 Small nucleotide variant , not otherwise specified - Targeted Variant Test TP604, TP613, TP622, TP640 cancer Targeted assay
GT1335 Chimerism by STR Testing - Post Solid Organ Transplant TP401 chimerism Targeted assay
GT1336 Chimerism by XY FISH - Post Solid Organ Transplant TP401 chimerism Targeted assay
GT1337 CD79B Hotspot (Y196 Variants) - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1338 Other FISH Targets - Mature T cell neoplasms TP58 haematological-oncology Targeted assay
GT1339 WGS Germline & Tumour - B Cell Lymphoma with 11q Aberration TP377 haematological-oncology Whole Genome Sequencing
GT1340 WGS Tumour First - AA TP202 haematological-oncology Whole Genome Sequencing
GT1341 WGS Germline & Tumour - B Cell Lymphoma with IRF4 Rearrangement TP377 haematological-oncology Whole Genome Sequencing
GT1342 WGS Germline & Tumour - Follicular Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1343 WGS Follow-up Germline - Follicular lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1344 WGS Germline & Tumour - Marginal Zone Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1345 Chromosome 17 CNV FISH - CML TP374 haematological-oncology Targeted assay
GT1346 Copy number variant, not otherwise specified - Targeted Variant Test TP604, TP622, TP640 cancer Targeted assay
GT1347 WGS Germline & Tumour - High Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1348 CIITA, 16p13 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1349 WGS Tumour First - Burkitt Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1350 WGS Germline & Tumour - Burkitt Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1351 WGS Follow-up Germline - High Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1352 WGS Germline & Tumour - Hepatosplenic T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1353 WGS Follow-up Germline - T Cell NHL TP58 haematological-oncology Whole Genome Sequencing
GT1354 ALK, 2p23 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1355 PDGFRB, 5q32 FISH - MPN TP228 haematological-oncology Targeted assay
GT1356 WGS Germline & Tumour - Low Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1357 WGS Follow-up Germline - CML TP374 haematological-oncology Whole Genome Sequencing
GT1358 WGS Tumour First - T Cell NHL TP58 haematological-oncology Whole Genome Sequencing
GT1359 WGS Follow-up Germline - ALK Negative Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1360 WGS Tumour First - ALK Positive Large B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1361 WGS Tumour First - Hepatosplenic T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1362 WGS Tumour First - ALK Negative Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1363 WGS Follow-up Germline - B Cell Lymphoma with 11q Aberration TP377 haematological-oncology Whole Genome Sequencing
GT1364 WGS Follow-up Germline - Hepatosplenic T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1365 WGS Follow-up Germline - Marginal Zone Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1366 WGS Follow-up Germline - Low Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1367 WGS Follow-up Germline - B Cell Lymphoma with IRF4 Rearrangement TP377 haematological-oncology Whole Genome Sequencing
GT1368 Chimerism by STR Testing - Post Stem Cell Transplant TP401 chimerism Targeted assay
GT1369 WGS Germline & Tumour - ALK Negative Anaplastic Large Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1370 Chimerism by XY FISH - Post Stem Cell Transplant TP401 chimerism Targeted assay
GT1371 BCR::ABL1, t(9;22)(q34;q11) FISH - CML TP374 haematological-oncology Targeted assay
GT1372 WGS Follow-up Germline - NK Cell/Gamma-Delta T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1373 WGS Tumour First - CML TP374 haematological-oncology Whole Genome Sequencing
GT1375 Karyotype - MDS TP202 haematological-oncology Chromosome analysis
GT1376 WGS Germline & Tumour - NK Cell/Gamma-Delta T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1377 WGS Tumour First - Low Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1378 WGS Germline & Tumour - ALK Positive Large B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1379 WGS Tumour First - Follicular Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1380 IGHV Hypermutation (NGS) - Hairy Cell Leukaemia TP377 haematological-oncology Sequencing
GT1381 WGS Germline & Tumour - Primary Mediastinal B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1382 WGS Germline & Tumour - AA TP202 haematological-oncology Whole Genome Sequencing
GT1383 WGS Follow-up Germline - ALK Positive Large B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1384 WGS Tumour First - NK Cell/Gamma-Delta T Cell Lymphoma TP58 haematological-oncology Whole Genome Sequencing
GT1385 ALK::NPM1, t(2;5)(p23;q35) FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT1386 WGS Germline & Tumour - T Cell NHL TP58 haematological-oncology Whole Genome Sequencing
GT1387 WGS Follow-up Germline - Primary Mediastinal B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1388 WGS Follow-up Germline - Burkitt Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1389 WGS Tumour First - Marginal Zone Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1390 WGS Tumour First - B Cell Lymphoma with 11q Aberration TP377 haematological-oncology Whole Genome Sequencing
GT1391 WGS Tumour First - Primary Mediastinal B Cell Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1392 WGS Tumour First - B Cell Lymphoma with IRF4 Rearrangement TP377 haematological-oncology Whole Genome Sequencing
GT1393 WGS Tumour First - High Grade Lymphoma TP377 haematological-oncology Whole Genome Sequencing
GT1394 MYC, 8q24 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1403 Gliomas, Glioneuronal Tumours, and Neuronal tumours Differential Diagnosis-NGS Panel SNV and CNV TP640 cancer Sequencing
GT1404 CD274 / PDCD1LG2, 9p24 FISH - Mature B Cell Neoplasms TP377 haematological-oncology Targeted assay
GT1405 Tumours of the Sellar Region and Pituitary Tumours Differential Diagnosis-NGS Panel SNV and CNV TP622 cancer Sequencing
GT1407 IGH::CCND1, t(11;14)(q13;q32) FISH - Mantle Cell Lymphoma TP377 haematological-oncology Targeted assay
GT1408 B Cell Clonality Testing - NGS TP62 haematological-oncology Sequencing
GT1411 Embryonal Tumours Differential Diagnosis-NGS Panel SNV and CNV TP604 cancer Sequencing
GT1413 Embryonal Tumours Differential Diagnosis-NGS Panel Structural Variant TP604 cancer Sequencing
GT1414 Next Generation Sequencing Panel - Copy Number Variant - CML TP374 haematological-oncology Sequencing
GT1415 Gliomas, Glioneuronal Tumours, and Neuronal tumours Differential Diagnosis-NGS Panel Structural Variants TP640 cancer Sequencing
GT1416 ALK, 2p23 FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT1418 Ependymal Tumours Differential Diagnosis-NGS Panel Structural Variants TP640 cancer Sequencing
GT1420 Meningiomas Differential Diagnosis-NGS Panel SNV and CNV TP613 cancer Sequencing
GT1422 Chromosome 8 CNV FISH - Mature T Cell Neoplasms TP58 haematological-oncology Targeted assay
GT1423 B Cell Clonality Testing - Multiplex Sequencing TP62 haematological-oncology Sequencing
GT1424 Chromosome 5 CNV FISH - CML TP374 haematological-oncology Targeted assay
GT1426 Next Generation Sequencing Panel - Small Variant - CML TP374 haematological-oncology Sequencing
GT1427 Choroid plexus tumours - NGS Panel SNV and CNV TP624 cancer Sequencing
GT1428 Choroid plexus tumours WGS - Paediatric and Adult TP624 cancer Whole Genome Sequencing
GT1429 Tumours of the CNS NOS including Rare tumours Differential Diagnosis-NGS Panel SNV and CNV TP625 cancer Sequencing
GT1430 Tumours of the CNS NOS including Rare tumours Differential Diagnosis-NGS Panel Structural Variant TP625 cancer Sequencing
GT1431 CNS of uncertain differentiation (NOS) and Rare Tumours WGS - Paediatric and Adult TP625 cancer Whole Genome Sequencing
GT1432 Gliomas, Glioneuronal Tumours, and Neuronal tumours WGS - Paediatric and Adult TP640 cancer Whole Genome Sequencing
GT1433 Tumours of the Sellar Region and Pituitary Tumours WGS - Paediatric and Adult TP622 cancer Whole Genome Sequencing
GT1434 Cranial and paraspinal nerve tumours Differential - NGS Panel SNV and CNV TP623 cancer Sequencing
GT1435 Cranial and paraspinal nerve tumours Differential - NGS Panel Structural Variant TP623 cancer Sequencing
GT1436 Cranial and paraspinal nerve tumours WGS- Paediatric and Adult TP623 cancer Whole Genome Sequencing
GT1439 WGS Tumour First - MDS TP202 haematological-oncology Whole Genome Sequencing
GT1497 MRD JAK2 Hotspot (V617F) - MPN TP228 haematological-oncology Targeted assay

Description of the above table(s).